Lack of development of Pneumocystis jirovecii Pneumonia in a cohort of 103 Italian glioblastoma patients not receiving prophylaxis during post-surgical chemoradiotherapy
Patients diagnosed with high grade gliomas (HGG) usually receive surgery, radiation, temozolomide (TMZ) and corticosteroids [1]. A major concern in patients who receive chemoradiotherapy (CRT) is the risk of developing secondary myelosuppression and a related infection during treatment [2], which in turn may lead to discontinuation of anti-tumor therapy and possibly to a worse outcome, although this is not unequivocally documented.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Nicola Rifino, Andrea Rigamonti, Francesco Maria Guida, Giuseppe De Nobili, Giannantonio Spena, Carlo Ferrarese, Andrea Salmaggi Tags: Letter to the Editor Source Type: research
More News: Brain | Brain Tumor | Corticosteroid Therapy | Glioma | Italy Health | Neurology | Neurosurgery | Pneumonia | Temodar